Log in
Enquire now
Genesis Therapeutics

Genesis Therapeutics

Pairing proven drug developers with the industry's most advanced small molecule discovery platform, to accelerate and optimize the development of new medicines.

OverviewStructured DataIssuesContributors

Contents

genesistherapeutics.ai
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Analytics
Analytics
Predictive analytics
Predictive analytics
Drug discovery
Drug discovery
Artificial Intelligence (AI)
Artificial Intelligence (AI)
Healthcare
Healthcare
Biotechnology
Biotechnology
...
Location
United States
United States
San Francisco
San Francisco
South San Francisco, California
South San Francisco, California
B2X
B2B2C
B2B2C
CEO
Evan Feinberg
Evan Feinberg
0
Founder
Ben Sklaroff
Ben Sklaroff
0
Evan Feinberg
Evan Feinberg
0
James Schaeffer
James Schaeffer
Pitchbook URL
pitchbook.com/profiles...343111-24
Number of Employees (Ranges)
11 – 50
Email Address
info@genesistherapeutics.ai
Number of Employees
26
Full Address
415 Grand Avenue Suite 201 South San Francisco, CA 94080 United States
Investors
The a16z Cultural Leadership Fund
The a16z Cultural Leadership Fund
Propagator Ventures
Propagator Ventures
0
Radical Ventures
Radical Ventures
0
Rock Springs Capital
Rock Springs Capital
Felicis Ventures
Felicis Ventures
Harpoon Ventures
Harpoon Ventures
Ulu Ventures
Ulu Ventures
0
JAZZ Venture Partners
JAZZ Venture Partners
...
Founded Date
2019
Total Funding Amount (USD)
56,100,000
Latest Funding Round Date
December 2020
Competitors
Owkin
Owkin
Business Model
Commerce
Latest Funding Type
Series A
Series A
Country
United States
United States

Other attributes

Company Operating Status
Active
Public/Private
Private

Genesis Therapeutics is a company that is interested in providing artificial intelligence and bio-technologies in order to discover new medicines. The company was founded in 2019, in San Francisco, California, United States.

The company looks to combine novel deep neural networks, biophysical simulations, and computing infrastructures. The company has an artificial intelligence platform that expands the initial discovery of the PotentialNet and peer-reviewed methods for molecular property predictions. Their methods have been tested against current methods of chemistry.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

VentureRadar | VentureRadar

https://www.ventureradar.com/organisation/Genesis%20Therapeutics/99e99fbe-c739-4a0a-89d1-693be0739699

Web

References

Find more companies like Genesis Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.